Related Experiment Video
Updated: Jun 13, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardiorenal syndromes--recommendations from clinical practice guidelines: the cardiologist's view
Insights
Evidence-based guidelines are challenging for heart failure patients with kidney disease due to limited research. Future trials must include these cardiorenal syndrome patients for better treatment understanding.
Area of Science:
- Cardiology
- Nephrology
- Clinical Practice Guidelines
Background:
- Cardiologists rely on evidence-based guidelines for clinical practice.
- Patients with heart failure and kidney disease (cardiorenal syndromes) lack specific clinical trials.
- These patients face high risks of complications, morbidity, and mortality.
Purpose of the Study:
- To highlight the challenges in managing cardiorenal syndromes.
- To emphasize the need for specific research in this patient population.
- To inform future clinical trial design for heart failure with renal insufficiency.
Main Methods:
- Review of current clinical practice challenges.
- Analysis of treatment applicability in heart failure with renal disease.
- Identification of research gaps in cardiorenal syndrome management.
Main Results:
- Current heart failure guidelines are not easily applicable to patients with kidney disease.
- Management of cardiorenal syndromes is often empirical.
- Standard heart failure drugs may not be suitable for patients with renal impairment.
Conclusions:
- There is a critical lack of evidence-based treatment strategies for cardiorenal syndromes.
- Future heart failure research must actively recruit patients with renal insufficiency.
- Inclusion of these patients is vital for understanding treatment impacts and improving outcomes.
Abstract:
In the past two decades European cardiologists have always been told to follow the evidence-based guidelines in their everyday clinical practice. In the case of patients with heart failure and concomitant renal disease, this universal rule is not easily applicable simply because there is a lack of specific trials in this field. Patients with cardiorenal syndromes are at risk of complications and have high morbidity and mortality. However, the management of these patients is often empirical. Drugs commonly recommended for the treatment of chronic and acutely decompensated heart failure are not always accepted for patients with concomitant renal disease. Future research trials in heart failure should include patients with renal insufficiency to allow better understanding of the impact of the current treatments available in patients with cardiorenal syndromes.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Chronic Kidney Disease IV: Nursing Management
Heart Failure VI: Adjunct Therapies